CTLA4Ig Improves Murine iTreg Induction via TGFβ and Suppressor Function In Vitro

Blockade of the CD28:CD80/86 costimulatory pathway has been shown to be potent in blocking T cell activation in vitro and in vivo. The costimulation blocker CTLA4Ig has been approved for the treatment of autoimmune diseases and transplant rejection. The therapeutic application of regulatory T cells...

Full description

Saved in:
Bibliographic Details
Main Authors: Nina Pilat, Benedikt Mahr, Martina Gattringer, Ulrike Baranyi, Thomas Wekerle
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2018/2484825
Tags: Add Tag
No Tags, Be the first to tag this record!